Krüppel-like factor 4 regulates genetic stability in mouse embryonic fibroblasts

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  El Karim, Enas A ^a   Hagos, Engda G ^b   Ghaleb, Amr M ^a   Yu, Bing ^a   Yang, Vincent W ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Center for Language and Brain   (United States)

Author keywords

Aneuploidy; Centrosome amplification; DNA damage responses; Genetic instability; KLF4; Mouse embryonic fibroblasts

Indexed keywords

CYTOCHALASIN B; HISTONE H2AX; KRUPPEL LIKE FACTOR 4;

ANEUPLOIDY; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE CHECKPOINT; CELL CYCLE PROGRESSION; CELL DIVISION; CELL PROLIFERATION; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME ANALYSIS; CHROMOSOME NUMBER; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; EMBRYO; FIBROBLAST; GAMMA IRRADIATION; GENE OVEREXPRESSION; GENETIC STABILITY; METAPHASE CHROMOSOME; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; NONHUMAN; NULL ALLELE; PROTEIN EXPRESSION;

ANEUPLOIDY; ANIMALS; CELL LINE; CELL PROLIFERATION; CENTROSOME; DNA DAMAGE; FIBROBLASTS; GENE EXPRESSION; GENE KNOCKOUT TECHNIQUES; GENOMIC INSTABILITY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; TRANSFECTION;

EID: 84881536528     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-89     Document Type: Article

References (49)

1. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J Biol Chem 1996, 271:20009-20017. 10.1074/jbc.271.33.20009, 2330254, 8702718.
2. Garrett-Sinha LA, Eberspaecher H, Seldin MF, de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem 1996, 271:31384-31390. 10.1074/jbc.271.49.31384, 8940147.
3. Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006, 6:11-23. 10.1038/nrc1780, 16372018.
4. Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res 2000, 60:6488-6495.
5. Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson AJ, et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 2005, 24:1491-1500. 10.1038/sj.onc.1208307, 1361530, 15674344.
6. Yang Y, Goldstein BG, Chao HH, Katz JP. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 2005, 4:1216-1221. 10.4161/cbt.4.11.2090, 16357509.
7. Zammarchi F, Morelli M, Menicagli M, Di Cristofano C, Zavaglia K, Paolucci A, Campani D, Aretini P, Boggi U, Mosca F, et al. KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. Am J Pathol 2011, 178:361-372. 10.1016/j.ajpath.2010.11.021, 3069861, 21224073.
8. Hu W, Hofstetter WL, Li H, Zhou Y, He Y, Pataer A, Wang L, Xie K, Swisher SG, Fang B. Putative tumor-suppressive function of Krüppel-like factor 4 in primary lung carcinoma. Clin Cancer Res 2009, 15:5688-5695. 10.1158/1078-0432.CCR-09-0310, 2745510, 19737957.
9. Kanai M, Wei D, Li Q, Jia Z, Ajani J, Le X, Yao J, Xie K. Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin Cancer Res 2006, 12:6395-6402. 10.1158/1078-0432.CCR-06-1034, 17085651.
10. Ohnishi S, Ohnami S, Laub F, Aoki K, Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F, Yoshida T. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun 2003, 308:251-256. 10.1016/S0006-291X(03)01356-1, 12901861.
11. Wang N, Liu ZH, Ding F, Wang XQ, Zhou CN, Wu M. Down-regulation of gut-enriched Krüppel-like factor expression in esophageal cancer. World J Gastroenterol 2002, 8:966-970.
12. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S, Xie K. Drastic down-regulation of Krüppel-like factor 4 expression is critical inhuman gastric cancer development and progression. Cancer Res 2005, 65:2746-2754. 10.1158/0008-5472.CAN-04-3619, 15805274.
13. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004, 23:395-402. 10.1038/sj.onc.1207067, 1351029, 14724568.
14. Nakahara Y, Northcott PA, Li M, Kongkham PN, Smith C, Yan H, Croul S, Ra YS, Eberhart C, Huang A, et al. Genetic and epigenetic inactivation of Krüppel-like factor 4 in medulloblastoma. Neoplasia 2010, 12:20-27. 2805880, 20072650.
15. Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW. Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 2005, 15:92-96. 10.1038/sj.cr.7290271, 1317089, 15740636.
16. Chen X, Johns DC, Geiman DE, Marban E, Dang DT, Hamlin G, Sun R, Yang VW. Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem 2001, 276:30423-30428. 10.1074/jbc.M101194200, 2330258, 11390382.
17. Yoon HS, Chen X, Yang VW. Krüppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem 2003, 278:2101-2105. 10.1074/jbc.M211027200, 2229830, 12427745.
18. Hagos EG, Ghaleb AM, Dalton WB, Bialkowska AB, Yang VW. Mouse embryonic fibroblasts null for the Krüppel-like factor 4 gene are genetically unstable. Oncogene 2009, 28:1197-1205. 10.1038/onc.2008.465, 2667867, 19137014.
19. Attardi LD. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. Mutat Res 2005, 569:145-157. 10.1016/j.mrfmmm.2004.04.019, 15603759.
20. Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005, 7:1074-1082. 10.1038/ncb1314, 16244670.
21. Mahatan CS, Kaestner KH, Geiman DE, Yang VW. Characterization of the structure and regulation of the murine gene encoding gut-enriched Krüppel-like factor (Krüppel-like factor 4). Nucleic Acids Res 1999, 27:4562-4569. 10.1093/nar/27.23.4562, 148743, 10556311.
22. Yoon HS, Ghaleb AM, Nandan MO, Hisamuddin IM, Dalton WB, Yang VW. Krüppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage. Oncogene 2005, 24:4017-4025. 10.1038/sj.onc.1208576, 1626272, 15806166.
23. Ghaleb AM, Katz JP, Kaestner KH, Du JX, Yang VW. Krüppel-like factor 4 exhibits antiapoptotic activity following gamma-radiation-induced DNA damage. Oncogene 2007, 26:2365-2373. 10.1038/sj.onc.1210022, 2230633, 17016435.
24. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 2002, 7:1128-1137. 10.1016/S1359-6446(02)02502-3, 12546856.
25. Kufe DW, Holland JF, Frei E, American Cancer Society., National Center for Biotechnology Information (U.S.) Holland Frei Cancer Medicine 6. NCBI bookshelf, 6th edition 2003, Hamilton, Ont.; Lewiston, NY: NCBI, Bethesda MD, Decker BC, American Cancer Society., National Center for Biotechnology Information (U.S.).
26. Yoon HS, Yang VW. Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 2004, 279:5035-5041. 1262649, 14627709.
27. Chen X, Whitney EM, Gao SY, Yang VW. Transcriptional profiling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. JMol Biol 2003, 326:665-677.
28. Hagos EG, Ghaleb AM, Kumar A, Neish AS, Yang VW. Expression profiling and pathway analysis of Krüppel-like factor 4 inMouse embryonic fibroblasts. Am J Cancer Res 2011, 1:85-97. 3165197,3165197, 21892412.
29. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS, Yang VW. The gut-enriched Kruppel-like factor (Krüppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/CIP1 promoter. J Biol Chem 2000, 275:18391-18398. 10.1074/jbc.C000062200, 2231805, 10749849.
30. Wei D, Kanai M, Jia Z, Le X, Xie K. Krüppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 2008, 68:4631-4639. 10.1158/0008-5472.CAN-07-5953, 2481517, 18559508.
31. Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC. Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res 2000, 28:2969-2976. 10.1093/nar/28.15.2969, 102679, 10908361.
32. Doxsey S. Re-evaluating centrosome function. Nat RevMol Cell Biol 2001, 2:688-698.
33. Fukasawa K. Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 2007, 7:911-924. 10.1038/nrc2249, 18004399.
34. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825. 10.1016/0092-8674(93)90500-P, 8242752.
35. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 54:1169-1174.
36. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci USA 1999, 96:1002-1007. 10.1073/pnas.96.3.1002, 15340, 9927683.
37. Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA, Fukasawa K. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 2000, 19:1635-1646. 10.1038/sj.onc.1203460, 10763820.
38. Rouse J, Jackson SP. Lcd1p recruitsMec1p to DNA lesions in vitro and in vivo. Mol Cell 2002, 9:857-869. 10.1016/S1097-2765(02)00507-5, 11983176.
39. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439. 10.1038/35044005, 11100718.
40. Dalton WB, Yu B, Yang VW. p53 suppresses structural chromosome instability after mitotic arrest inhuman cells. Oncogene 2010, 29:1929-1940. 10.1038/onc.2009.477, 2848712, 20062083.
41. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004, 432:316-323. 10.1038/nature03097, 15549093.
42. Jackson SP, Bartek J. The DNA-damage response inhuman biology and disease. Nature 2009, 461:1071-1078. 10.1038/nature08467, 2906700, 19847258.
43. Guirouilh-Barbat JK, Wilhelm T, Lopez BS. AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers. Oncotarget 1:691-699.
44. Schultz LB, Chehab NH, Malikzay A, DiTullio RA, Stavridi ES, Halazonetis TD. The DNA damage checkpoint and human cancer. Cold Springharb Symp Quant Biol 2000, 65:489-498.
45. Xie W, Wang K, Robertson LW, Ludewig G. Investigation of mechanism(s) of DNA damage induced by 4-monochlorobiphenyl (PCB3) metabolites. Environ Int 2010, 36:950-961. 10.1016/j.envint.2009.12.004, 2888624, 20129669.
46. Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsiere T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res 2008, 658:215-233. 10.1016/j.mrrev.2007.10.001, 18037339.
47. Patel NV, Ghaleb AM, Nandan MO, Yang VW. Expression of the tumor suppressor Krüppel-like factor 4 as a prognostic predictor for colon cancer. Cancer Epidemiol Biomarkers Prev 2010, 19:2631-2638. 10.1158/1055-9965.EPI-10-0677, 2952064, 20699379.
48. Du JX, McConnell BB, Yang VW. A small ubiquitin-related modifier-interacting motif functions as the transcriptional activation domain of Krüppel-like factor 4. J Biol Chem 2010, 285:28298-28308. 10.1074/jbc.M110.101717, 2934694, 20584900.
49. Lee JJ, Warburton D, Robertson EJ. Cytogenetic methods for the mouse: preparation of chromosomes, karyotyping, and in situhybridization. Anal Biochem 1990, 189:1-17. 10.1016/0003-2697(90)90036-9, 2278379.